Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Much Will The Phosphoramidite Market Be Worth By 2029?

In recent times, there has been notable progress in the phosphoramidite market size. The expectation is a leap from $1.01 billion in 2024 to $1.07 billion in 2025, revealing a compound annual growth rate (CAGR) of 6.1%. Several influences led to this growth during the historic period, including a surge in demand for DNA and RNA synthesis, greater use of mRNA-based treatments, increasing cases of genetic disorders, an escalated demand in synthetic biology, and an uptick in investments towards genomic research.

In the coming years, the phosphoramidite market is anticipated to witness substantial growth, swelling to a size of “$1.4 billion in 2029” with a compound annual growth rate (CAGR) of 7.0%. This growth trajectory during the forecast period is linked to factors such as increased use of phosphoramidites, heightened demand for customized DNA and RNA synthesis, rising requirement for high-purity phosphoramidites, the growing focus on personalized medicine, and the expansion of biopharmaceutical firms. Trend indicators for the forecast period include the spread of synthetic biology, the creation of unique phosphoramidite chemistries, advancements in genomic technologies, development endeavours in the biotechnology field, and the progress of personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Are The Primary Factors Supporting The Phosphoramidite Market Expansion?

The phosphoramidite market is set to witness significant growth due to the expanding biopharmaceutical sector. The biopharmaceutical sector entails industries involved in the R&D, manufacturing, and commercialization of medical products derived biologically, including recombinant proteins, monoclonal antibodies, gene therapies, and vaccines. Factors like advancements in biotechnology, a high occurrence of chronic illnesses, and increased investment in R&D are fuelling this growth. Biotech breakthroughs such as monoclonal antibody treatments and gene editing have paved the way for targeted and more efficient therapies. Phosphoramidite, being crucial in the synthesis of RNA and DNA for mRNA vaccines, gene therapies, and oligonucleotide-based drugs, will see increased demand with the expansion of the biopharmaceutical sector. As these therapies gain popularity, the requirement for phosphoramidites in producing synthetic nucleic acids will heighten, thus, amplifying their application in biopharmaceutical research and production. For instance, the UK government states that the core biopharmaceutical sector generated £46.7 ($58.4 billion) billion in revenue in 2022, accounting for 43% of the total turnover of the life sciences industry. Moreover, it supports over 126,000 jobs and has seen significant growth in R&D investments. Consequently, the growing biopharmaceutical sector is propelling the phosphoramidite market’s expansion.

How Does The Phosphoramidite Market Differ By Segment?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

What New Opportunities Are Emerging From Trends In The Phosphoramidite Market?

Leading firms in the phosphoramidite market are prioritizing the development of innovative DNA synthesis services to improve efficiency, speed, and sustainability, while also minimizing hazardous waste produced during DNA production. Enzymes, rather than chemical reagents, are used in the DNA synthesis method, resulting in heightened accuracy, speed, and sustainability. For example, in April 2022, Ansa Biotechnologies Inc., a biotech firm based in the US, declared the completion of a $68 million Series A financing round that was oversubscribed. Northpond Ventures led this round, which received support from a range of both new and existing investors. The purpose of this funding is to expedite the progress of Ansa’s subsequent enzymatic DNA synthesis technology, also known as phosphoramidite synthesis, develop its R&D and manufacturing infrastructure, and initiate a tailored DNA synthesis service. The company, which evolved from the University of California, Berkeley, employs a patented technique enabling quick and precise long DNA sequence synthesis, addressing current industry challenges.

Who Are The Global Leaders Steering The Phosphoramidite Market Forward?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2024. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model